Medicamen targets new equity raise
Medicamen has recently won a new long term contract manufacturing contract from a US distributor. Company has now announced a board meeting on February 26, 2025 to consider a new fund raise. The intention is to raise some sort of equity (direct or convertible) by way of Preferential Issue/ Rights Issue/ QIP/ or any other … Read more